Tissue Oxygen Use With Combined Arteriovenous Noninvasive Oximetry

NCT ID: NCT06072755

Last Updated: 2024-08-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-11

Study Completion Date

2024-07-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to find out if researchers can measure oxygen consumption in the body without having to draw blood from lines in arteries and central veins.

Participants will undergo measurements of arterial blood oxygen saturation using both finger and neck pulse oximeters.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

TOUCAN-1 is a study to estimate the accuracy and precision of pulse oximetry as a noninvasive tool for oxygen consumption measurement. Researchers will use a pair of commercially-available, noninvasive pulse oximeters to estimate the oxygen saturation of blood in the internal jugular vein, and compare it to the directly measured oxygen saturation in sampled jugular blood. Researchers will then measure the arterial oxygen saturation in a finger, and compare it to the directly measured oxygen saturation in sampled radial arterial blood.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oxygen Consumption

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Critically ill adults

Inpatient adults who require internal jugular venous central line and radial arterial line

Finger pulse oximetry probe

Intervention Type DEVICE

This finger probe will be used to make noninvasive measurements of systemic arterial and central venous oxygen saturations.

Transreflectance oximetry probe

Intervention Type DEVICE

This neck probe will be used to make noninvasive measurements of systemic arterial and central venous oxygen saturations.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Finger pulse oximetry probe

This finger probe will be used to make noninvasive measurements of systemic arterial and central venous oxygen saturations.

Intervention Type DEVICE

Transreflectance oximetry probe

This neck probe will be used to make noninvasive measurements of systemic arterial and central venous oxygen saturations.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Inpatient at the University of Wisconsin University Hospital
* Has an internal jugular venous central line
* Has a radial arterial line

Exclusion Criteria

* Currently receiving extracorporeal membrane oxygenation (ECMO)
* Currently receiving continuous renal replacement therapy (CRRT/CVVH)
* All usable lumens of the participant's jugular catheter are in use, and interruption of any medical or therapy through any lumen would, in the view of the primary care team, compromise the participant's care.
* Jugular venous catheter is not functional or position is not confirmed by radiography
* Arterial cannula is not functional
* Known history of sickle cell anemia or other hemoglobinopathy
* Therapy with any of the following medications:

* Nitroprusside
* Hydroxocobalamin
* Indocyanine green
* Norepinephrine
* Vasopressin
* Epinephrine
* Any other medication or therapy that, in the judgement of the study investigators, may affect the accuracy and precision of the noninvasive oximetry results
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AABB Foundation

UNKNOWN

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aaron S Hess, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Wisconsin

Madison, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SMPH/ANESTHESIOLOGY/ANESTHESIO

Identifier Type: OTHER

Identifier Source: secondary_id

Protocol Version 9/20/2023

Identifier Type: OTHER

Identifier Source: secondary_id

FP00002636

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

2023-1317

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pulse Oximeter Hypoxia
NCT04562584 COMPLETED NA